Valiant Co

Valiant Co R&D Expenses

The Research & Development Expenses of Valiant Co (002643.SZ) as of Nov 19, 2026 is 438.55 M CNY. In the previous year, Research & Development Expenses was 427.78 M CNY — a change of 2.52% (higher).

R&D Expenses

438.55 MCNY

YoY

2.52%

Last updated:

Research & Development Expenses of Valiant Co is 2025 438.55 M CNY. Research & Development Expenses of Valiant Co was 2024 427.78 M CNY. It decreases by 2.52% higher compared to the previous year.

The Valiant Co R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2018
193.57 M CNY
Jan 1, 2019
251.39 M CNY
Jan 1, 2020
249.88 M CNY
Jan 1, 2021
295.32 M CNY
Jan 1, 2022
357.52 M CNY
Jan 1, 2023
368.15 M CNY
Jan 1, 2024
427.78 M CNY
Jan 1, 2025
438.55 M CNY
The Valiant Co R&D Expenses history
YEARR&D ExpensesYoY
438.55 MCNY+2.52%
427.78 MCNY+16.20%
368.15 MCNY+2.97%
357.52 MCNY+21.06%
295.32 MCNY+18.19%
249.88 MCNY-0.60%
251.39 MCNY+29.87%
193.57 MCNY+5.99%
182.63 MCNY+91.49%
95.37 MCNY-30.64%
137.50 MCNY+43.29%
95.96 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

Research & Development Expenses of Valiant Co is 438.55 M CNY in 2025.

Research & Development Expenses of Valiant Co changed from 427.78 M CNY to 438.55 M CNY, representing a 2.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Valiant Co since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Valiant Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Valiant Co

All Key Metrics — Valiant Co